Lack of evidence for the selection of E138 mutations by first-generation non-nucleoside reverse transcriptase inhibitors in patients infected with HIV-1 non-B subtypes

Ana B. Abecasis, Kristel van Laethem, Kristof Theys

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)987-988
Number of pages2
JournalAIDS
Volume29
Issue number8
DOIs
Publication statusPublished - 15 May 2015

Keywords

  • ANTIRETROVIRAL THERAPY
  • VIROLOGICAL FAILURE
  • RESISTANCE

UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-Being

Cite this